Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
Crunch Health Opens New Facility in Auburn, Alabama Presale Launch Social gathering Jan 6
AUBURN, Ala., January 4, 2022 / PRNewswire / - Crunch Franchise Announces the Opening of Crunch Auburn, Wednesday January 12th, one $ 5 million,...
Main Telehealth Agency, Assist Your Diabetes, Engages NMS Consulting as Strategic Advisor for Gross...
The world's leading diabetes reversal program
...